Tradestie Institutional Equity Comparison Engine

NVS vs PFE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NVS Overall Edge

NVS Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Novartis AG (NVS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NVS trades at 16.1x Forward P/E with 34.0% operating margin (+4.7% YoY revenue) versus PFE at 9.8x Forward P/E and 29.1% operating margin (-0.4% YoY). In options structure, NVS sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro) against PFE sits in CONSOLIDATION (33rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner NVS
NVS 16.1x vs PFE 9.8x Fwd P/E
Growth & Margin Winner NVS
Op Margin 34.0% vs 29.1% ยท YoY +4.7% vs -0.4%
Momentum & Technical Winner NVS
1Y +21.3% vs +13.5% ยท 52W Pos 76% vs 62%
Options & Structure Winner NVS
UNCLASSIFIED (6th %ile IV) vs CONSOLIDATION (33rd %ile IV)
NVS NYSE
Novartis AG
Pharmaceutical Preparations
$159.20
-0.62% 1D
Market Cap $303.1B
1M Return +5.99%
1Y Return +21.29%
Forward P/E 16.1x
Unified AI Score
42.2 / 100 HOLD
Tech 33.0 Fund 38.0 Flow 50.0 Mom 31.1
PFE NYSE
Pfizer Inc.
Pharmaceutical Preparations
$28.45
-1.42% 1D
Market Cap $164.7B
1M Return -3.36%
1Y Return +13.53%
Forward P/E 9.8x
Unified AI Score
52.3 / 100 HOLD
Tech 32.0 Fund 54.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NVS +21.29% PFE +13.53% Spread: +7.76 pp (NVS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NVS TTM Op. Margin: 34.0% PFE TTM Op. Margin: 29.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NVS vs PFE. Trailing 12-month operating profitability (NVS 34.0% vs PFE 29.1%) and valuation multiples (NVS 16.1x vs PFE 9.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NVS (7) vs PFE (3)
Institutional Metric NVS PFE Criterion Row Winner
Market Capitalization Scale $303.1B $164.7B Larger Scale NVS
Trailing P/E Ratio Valuation 30.6x 41.3x Lower Multiple NVS
Forward P/E Ratio Valuation 16.1x 9.8x Lower Multiple PFE
Revenue Growth (YoY) Growth +4.7% -0.4% Higher Growth NVS
Operating Margin (TTM) Profitability 34.0% 29.1% Higher Margin NVS
Net Profit Margin Profitability 17.5% 6.3% Higher Margin NVS
Return on Equity (ROE) Capital Efficiency 24.3% 4.5% Higher ROE NVS
52-Week Range Position Momentum 76% ($123โ€“$170) 62% ($24โ€“$31) Stronger Trend NVS
Beta / 30D Volatility Risk Regime 0.31ฮฒ ยท 26% Vol 0.18ฮฒ ยท 24% Vol Lower Realized Risk PFE
Unified Institutional Score Composite Signal 42.2 / 100 (HOLD) 52.3 / 100 (HOLD) Higher Composite PFE

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NVS vs PFE Buy Guide
NVS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live NVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PFE CONSOLIDATION
53d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 33rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live PFE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NVS nor PFE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.